Literature DB >> 8104727

Haemodynamic effects of rocuronium during fentanyl anaesthesia: comparison with vecuronium.

E P McCoy1, V R Maddineni, P Elliott, R K Mirakhur, I W Carson, R A Cooper.   

Abstract

Haemodynamic variables were measured following administration of rocuronium 0.6 mg.kg-1 or vecuronium 0.08 mg.kg-1 (approximately equivalent to 2 x ED95 doses) in patients anaesthetized with fentanyl 50 micrograms.kg-1 and scheduled to undergo elective coronary artery bypass grafting. There were increases in stroke volume index (+15%) and cardiac index (+11%), and a decrease in pulmonary capillary wedge pressure (-25%) following administration of rocuronium (P < 0.05). The changes in heart rate (+7%), mean arterial pressure (-5%), systemic vascular resistance (-12%) and other measured or derived indices were insignificant. In comparison the administration of vecuronium was associated with decreases in heart rate (-7%), mean pulmonary artery pressure (-17%), central venous pressure (-15%) and the rate-pressure product (-9%) (P < 0.05). The changes in mean arterial pressure (-7%), cardiac index (-6%) and systemic vascular resistance (-8%) following vecuronium were insignificant. There were no differences in any of the variables between rocuronium and vecuronium. The absolute values of all variables were, however, within acceptable clinical limits. There was no evidence of histamine release in any patient. The present study shows that rocuronium 0.6 mg.kg-1 is associated with changes of only small magnitude in haemodynamic variables.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104727     DOI: 10.1007/BF03009764

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  25 in total

1.  Comparison of intubating conditions after administration of Org 9246 (rocuronium) and suxamethonium.

Authors:  R Cooper; R K Mirakhur; R S Clarke; Z Boules
Journal:  Br J Anaesth       Date:  1992-09       Impact factor: 9.166

2.  The neuromuscular blocking effect of Org 9426. A new intermediately-acting steroidal non-depolarising muscle relaxant in man.

Authors:  L H Booij; H T Knape
Journal:  Anaesthesia       Date:  1991-05       Impact factor: 6.955

3.  Probable histamine liberation with atracurium. A case report.

Authors:  G G Lavery; M M Boyle; R K Mirakhur
Journal:  Br J Anaesth       Date:  1985-08       Impact factor: 9.166

4.  Comparison of large dose of vecuronium with pancuronium for prolonged neuromuscular blockade.

Authors:  K Rørvik; P Husby; L Gramstad; J S Vamnes; L Bitsch-Larsen; M E Koller
Journal:  Br J Anaesth       Date:  1988-08       Impact factor: 9.166

5.  An unusual case of sinus arrest.

Authors:  I Kirkwood; R A Duckworth
Journal:  Br J Anaesth       Date:  1983-12       Impact factor: 9.166

6.  Cutaneous reaction after atracurium.

Authors:  R K Mirakhur; S M Lyons; I W Carson; R S Clarke; C J Ferres; J W Dundee
Journal:  Anaesthesia       Date:  1983-08       Impact factor: 6.955

7.  Does perioperative myocardial ischemia lead to postoperative myocardial infarction?

Authors:  S Slogoff; A S Keats
Journal:  Anesthesiology       Date:  1985-02       Impact factor: 7.892

8.  Clinical observations on the neuromuscular blocking action of Org 9426, a new steroidal non-depolarizing agent.

Authors:  J M Wierda; A P de Wit; K Kuizenga; S Agoston
Journal:  Br J Anaesth       Date:  1990-04       Impact factor: 9.166

9.  Atracurium in clinical anaesthesia: effect of dosage on onset, duration and conditions for tracheal intubation.

Authors:  R K Mirakhur; G G Lavery; R S Clarke; F M Gibson; E McAteer
Journal:  Anaesthesia       Date:  1985-08       Impact factor: 6.955

10.  The effect of atracurium, vecuronium and pancuronium on heart rate and arterial pressure in normal individuals.

Authors:  G G Lavery; R K Mirakhur; R S Clarke; F M Gibson
Journal:  Eur J Anaesthesiol       Date:  1986-11       Impact factor: 4.330

View more
  8 in total

Review 1.  Newer neuromuscular blocking agents: how do they compare with established agents?

Authors:  H J Sparr; T M Beaufort; T Fuchs-Buder
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Investigation of the cardiac effects of pancuronium, rocuronium, vecuronium, and mivacurium on the isolated rat atrium.

Authors:  Sinan Gursoy; Ihsan Bagcivan; Nedim Durmus; Kenan Kaygusuz; Iclal Ozdemir Kol; Cevdet Duger; Sahin Yildirim; Caner Mimaroglu
Journal:  Curr Ther Res Clin Exp       Date:  2011-10

Review 3.  Clinical pharmacokinetics of rocuronium bromide.

Authors:  K S Khuenl-Brady; H Sparr
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

4.  Effect of Smoking on Reversing Neuromuscular Block.

Authors:  Ömür Öztürk; Gülbin Yalçın Sezen; Handan Ankaralı; Onur Özlü; Yavuz Demiraran; Hakan Ateş; Burhan Dost
Journal:  Turk J Anaesthesiol Reanim       Date:  2016-08-01

Review 5.  Neuromuscular transmission and its pharmacological blockade. Part 2: Pharmacology of neuromuscular blocking agents.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

6.  Hemodynamic profiles of intubated and mechanically ventilated carbon monoxide-poisoned patients during systemic hyperbaric oxygen therapy.

Authors:  Marie-Ludivine Chateau-Degat; Julien Poitras; Jacques H Abraini
Journal:  BMC Anesthesiol       Date:  2013-09-27       Impact factor: 2.217

Review 7.  New developments in nondepolarizing muscle relaxants.

Authors:  R K Mirakhur
Journal:  Yale J Biol Med       Date:  1993 Sep-Oct

8.  Intraoperative hemodynamics with vecuronium bromide and rocuronium for maintenance under general anesthesia.

Authors:  Alen Mathew; Anish N G Sharma; P Ganapathi; P Shankaranarayana; M Nazim; D S Aiyappa
Journal:  Anesth Essays Res       Date:  2016 Jan-Apr
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.